Cargando…
Haloperidol as a treatment option in cannabinoid hyperemesis syndrome
Autores principales: | Stawinski, Peter, Dziadkowiec, Karolina, Sah, Amit, Marcus, Akiva |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9743336/ https://www.ncbi.nlm.nih.gov/pubmed/36514445 http://dx.doi.org/10.5114/pg.2022.121826 |
Ejemplares similares
-
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting
por: Jones, Jennifer L., et al.
Publicado: (2016) -
Cannabinoid hyperemesis syndrome as an unusual cause of cyclic vomiting
por: Ramadurai, Srinivasan, et al.
Publicado: (2016) -
Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome
por: Bonnet, Udo
Publicado: (2022) -
A focused, longitudinal analysis of cannabinoid hyperemesis syndrome symptomatology
por: Ma, Philip H., et al.
Publicado: (2021) -
Reply to Letter “Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome”
por: Senderovich, Helen, et al.
Publicado: (2022)